Optimizing Preclinical Models to Determine Gene Therapy Safety & Efficacy
Time: 2:45 pm
day: Day One: Track A PM
Details:
- Preclinical development of AAV gene therapies for neurological disorders
- Considerations for the development of AAV gene therapies
- Preclinical development of AAV gene therapies
